Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
Andrew H. Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 4, pp. 1253-1260
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Queenie Fernandes, Varghese Inchakalody, Maysaloun Merhi, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 524-540
Open Access | Times Cited: 372
Vaccination in patients with kidney failure: lessons from COVID-19
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 79
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response
Andrew H. Karaba, Trevor S. Johnston, Tihitina Y. Aytenfisu, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1440-1444
Open Access | Times Cited: 67
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
Chiara Corti, Gabriele Antonarelli, Florian Scotté, et al.
Annals of Oncology (2021) Vol. 33, Iss. 2, pp. 158-168
Open Access | Times Cited: 70
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients
Ayman Al Jurdi, Rodrigo Benedetti Gassen, Thiago J. Borges, et al.
Kidney International (2022) Vol. 101, Iss. 6, pp. 1282-1286
Open Access | Times Cited: 49
Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults
Janna R. Shapiro, Ioannis Sitaras, Han Sol Park, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_1, pp. S61-S71
Open Access | Times Cited: 43
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Ana Cristina de Medeiros Ribeiro, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1036-1043
Open Access | Times Cited: 39
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
Delphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 5, pp. 649-658
Open Access | Times Cited: 24
Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era
Allan B. Massie, William A. Werbel, Robin K. Avery, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 8, pp. 2077-2082
Open Access | Times Cited: 36
Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
Aura T. Abedon, Mayan Teles, Jennifer L. Alejo, et al.
Transplantation (2022) Vol. 106, Iss. 5, pp. e262-e263
Open Access | Times Cited: 35
Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis
Kai Wang, Lin Wang, Mingzhe Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 33
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients
Quentin Perrier, Julien Lupo, Théophile Gerster, et al.
Vaccine (2022) Vol. 40, Iss. 44, pp. 6404-6411
Open Access | Times Cited: 28
COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children
Katerina Roznik, Jiashu Xue, Georgia Stavrakis, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching
J. Lee, Jaiprasath Sachithanandham, John S. Lee, et al.
Microbiology Spectrum (2025)
Open Access
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients
Maria Guarino, Ilaria Esposito, Giuseppe Portella, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 7, pp. 1534-1541.e4
Open Access | Times Cited: 24
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
Angioletta Lasagna, Federica Bergami, Daniele Lilleri, et al.
ESMO Open (2022) Vol. 7, Iss. 2, pp. 100458-100458
Open Access | Times Cited: 24
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19
William A. Werbel, Dorry L. Segev
American Journal of Transplantation (2022) Vol. 22, Iss. 5, pp. 1316-1320
Open Access | Times Cited: 22
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
Felix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 2, pp. 292-300
Open Access | Times Cited: 22
Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose
William A. Werbel, Andrew H. Karaba, Teresa Po‐Yu Chiang, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 6, pp. 744-758
Open Access | Times Cited: 14
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
Nora Pisanic, Annukka A.R. Antar, Kate Kruczynski, et al.
Journal of Immunological Methods (2023) Vol. 514, pp. 113440-113440
Open Access | Times Cited: 13
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort
Maddalena Giannella, Manuel Huth, Elda Righi, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 8, pp. 1084.e1-1084.e7
Open Access | Times Cited: 12
SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge
Bezawit A. Woldemeskel, Caroline C. Garliss, Tihitina Y. Aytenfisu, et al.
JCI Insight (2022) Vol. 7, Iss. 10
Open Access | Times Cited: 20
Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
Teresa Po‐Yu Chiang, Jennifer L. Alejo, Jonathan Mitchell, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 9, pp. 2254-2260
Open Access | Times Cited: 19
Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients
Floriane Gallais, Benjamin Renaud‐Picard, Morgane Solis, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 41, Iss. 10, pp. 1429-1439
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top